PpENK gene methylation status in the development of pancreatic carcinoma

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Yang, Lixin ^a   Yang, Hong ^b   Li, Jingnan ^b   Hao, Jianyu ^a   Qian, Jiaming ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROENKEPHALIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PANCREAS CARCINOMA; POLYMERASE CHAIN REACTION;

EID: 84879330878     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/130927     Document Type: Article

References (16)

1. Brune K., Hong S. M., Li A., Yachida S., Abe T., Griffith M., Yang D., Omura N., Eshleman J., Canto M., Schulick R., Klein A. P., Hruban R. H., Iacobuzio-Donohue C., Goggins M., Genetic and epigenetic alterations of familial pancreatic cancers. Cancer Epidemiology Biomarkers and Prevention 2008 17 12 3536 3542 2-s2.0-57449111916 10.1158/1055-9965.EPI-08-0630
2. Comb M., Seeburg P. H., Adelman J., Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA. Nature 1982 295 5851 663 666 2-s2.0-0020036185
3. Zagon I. S., McLaughlin P. J., Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells. International Journal of Oncology 2004 24 6 1443 1448 2-s2.0-16544364702
4. Lowenfels A. B., Maisonneuve P., Epidemiology and prevention of pancreatic cancer. Japanese Journal of Clinical Oncology 2004 34 5 238 244 2-s2.0-3342997700 10.1093/jjco/hyh045
5. Wolffe A. P., Matzke M. A., Epigenetics: regulation through repression. Science 1999 286 5439 481 486 2-s2.0-0033569641 10.1126/science.286.5439.481
6. Egger G., Liang G., Aparicio A., Jones P. A., Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004 429 6990 457 463 2-s2.0-2642531973 10.1038/nature02625
7. Herman J. G., Graff J. R., Myöhänen S., Nelkin B. D., Baylin S. B., Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Sciences of the United States of America 1996 93 18 9821 9826 2-s2.0-0029843950 10.1073/pnas.93.18.9821
8. Zagon I. S., Smith J. P., McLaughlin P. J., Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. International Journal of Oncology 1999 14 3 577 584 2-s2.0-0033090992
9. Ueki T., Toyota M., Sohn T., Yeo C. J., Issa J. J., Hruban R. H., Goggins M., Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Research 2000 60 7 1835 1839 2-s2.0-0034075153
10. Derks S., Lentjes M. H. F. M., Hellebrekers D. M. E. I., De Bruïne A. P., Herman J. G., Van Engeland M., Methylation-specific PCR unraveled. Cellular Oncology 2004 26 5-6 291 299 2-s2.0-21444451584
11. Zagon I. S., Hytrek S. D., Lang C. M., Smith J. P., Mcgarrity T. J., Wu Y., Mclaughlin P. J., Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer. American Journal of Physiology 1996 271 3 R780 R786 2-s2.0-0029840010
12. Zagon I. S., Hytrek S. D., Smith J. P., McLaughlin P. J., Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice. Cancer Letters 1997 112 2 167 175 2-s2.0-0031590965 10.1016/S0304-3835(96)04566- 1
13. Momparler R. L., Epigenetic therapy of cancer with 5-aza-2′- deoxycytidine (decitabine). Seminars in Oncology 2005 32 5 443 451 2-s2.0-25844465921 10.1053/j.seminoncol.2005.07.008
14. Jiao L., Zhu J., Hassan M. M., Evans D. B., Abbruzzese J. L., Li D., K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. Pancreas 2007 34 1 55 62 2-s2.0-33846017682 10.1097/01.mpa.0000246665.68869.d4
15. Ohtsubo K., Watanabe H., Yao F., Okada G., Mouri H., Yamaguchi Y., Sawabu N., Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma. Journal of Gastroenterology 2006 41 8 791 797 2-s2.0-33749008234 10.1007/s00535-006-1857-3
16. Matsubayashi H., Canto M., Sato N., Klein A., Abe T., Yamashita K., Yeo C. J., Kalloo A., Hruban R., Goggins M., DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Research 2006 66 2 1208 1217 2-s2.0-31544477679 10.1158/0008-5472.CAN-05-2664